Brewin Dolphin Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $38K | Hold |
268
| – | – | ﹤0.01% | 206 |
|
|
2022
Q1 | $46K | Buy |
268
+184
| +219% | +$31.6K | 0.01% | 198 |
|
|
2021
Q4 | $21K | Sell |
84
-170
| -67% | -$42.5K | ﹤0.01% | 258 |
|
|
2021
Q3 | $97.8K | Sell |
254
-55
| -18% | -$21.2K | 0.01% | 158 |
|
|
2021
Q2 | $72.6K | Buy |
309
+225
| +268% | +$52.9K | 0.01% | 169 |
|
|
2021
Q1 | $11K | Sell |
84
-140
| -63% | -$18.3K | ﹤0.01% | 286 |
|
|
2020
Q4 | $23.4K | Buy |
224
+140
| +167% | +$14.6K | ﹤0.01% | 217 |
|
|
2020
Q3 | $5.94K | Buy |
+84
| New | +$5.94K | ﹤0.01% | 250 |
|